• where experts go to learn about FDA
  • Jennifer D. Newberger

    • A Busy Day in the (CDRH) Neighborhood: Updates to the CDS and General Wellness Guidance DocumentsJanuary 8th, 2026

      On January 6, 2026, FDA issued two revised guidance documents related to clinical decision support (CDS) software and low-risk general wellness products. In a video announcing the revised guidance documents, Commissioner Makary states that they are intended to “cut unnecessary regulation and promote innovation” in …

    • Are the Kids All Right? FDA Warning Letters Put FDA in a BindDecember 31st, 2025

      On December 16, CDRH issued 12 Warning Letters to manufacturers and retailers of breast binders.  The Warning Letters were posted on FDA’s website 2 days later. According to the Warning Letters, the products offered by these companies are intended to compress breast tissue and create …

    • Calling VC Firms: FDA Wants to Work With YouDecember 29th, 2025

      FDA wants to capitalize on the talent of venture capital (VC) firms that are developing innovative solutions that can be applied to FDA’s public health mission. On December 17, 2025, FDA issued a Request for Information (RFI) for its FIRE program, which stands for “Foundational …

    • Recalls: They Aren’t Over ‘Til FDA Says So, But Who Knows When That Will BeDecember 22nd, 2025

      On December 8, 2025, the Government Accountability Office (GAO) sent a report to Senators Richard Durbin and Richard Blumenthal in response to the Senators’ request for GAO to review FDA’s medical device recall process. At a high level, the findings are not surprising—FDA’s staffing is …

    • You Better Move Fast: ACCESS to TEMPODecember 8th, 2025

      On December 5, FDA’s Digital Health Center of Excellence announced the “Technology-Enabled Meaningful Patient Outcomes (TEMPO) for Digital Health Devices Pilot,” in conjunction with the Center for Medicare and Medicaid Innovation (CMMI) Advancing Chronic Care with Effective, Scalable Solutions (ACCESS) model. FDA’s press release states …

    • HHS Divided: Can Consumers be Trusted with Low-Risk Products?October 10th, 2025

      Secretary of Health and Human Services Robert F. Kennedy, Jr., did not hide his disdain for FDA prior to his appointment, stating: FDA’s war on public health is about to end. This includes its aggressive suppression of psychedelics, peptides, stem cells, raw milk, hyperbaric therapies, chelating …

    • Request for Comments: AI-Enabled Medical DevicesOctober 3rd, 2025

      On September 30, 2025, FDA released a Request for Public Comment: Measuring and Evaluating Artificial Intelligence-enabled Medical Device Performance in the Real-World. Comments are due to the docket by December 1, 2025. The request for comments is to obtain feedback about the “current, practical approaches to …

    • Medical Device Weaponization: Section 232 InvestigationSeptember 30th, 2025

      On September 26, 2025, the Department of Commerce published a notice requesting public comment on “an investigation to determine the effects on the national security of imports of personal protective equipment (PPE), medical consumables, and medical equipment including devices.” 90 Fed. Reg. 46383 (Sept. 26, …

    • What Does a DOJ Settlement Have in Common with a Good Book? They Both can Change Your Life*August 15th, 2025

      The authors of this post are both avid bibliophiles, and keenly appreciate the hook of a good title or first sentence that draws you right in. Usually the titles of government press releases do not share this allure, but there was one recently that caught …

    • A Software Demo is Worth a Submission Full of Screenshots, But Is An Early Orientation Meeting Worth the Time?July 30th, 2025

      On July 24, 2025, FDA released the Regulatory Accelerator, an initiative to help digital health sponsors bring their technology to market. New developers may want to bookmark this link as the initiative neatly corrals information in one place. For those who have been working in …

    • To Meet or Not to Meet: Day 70 and CountingJuly 18th, 2025

      Recent communications from CDRH indicate that impacts to resources from Reductions-In-Force are causing some Offices in CDRH to delay granting a request for a pre-submission (or Q-Submission) meeting until after written feedback is provided. In a pre-submission, the Sponsor can request written feedback only, but …

    • Blood Pressure Rising: FDA Warning Letter Takes an Aggressive Approach on General Wellness ProductJuly 17th, 2025

      At the end of June, HHS Secretary Robert F. Kennedy told a House congressional committee that he would like to see all Americans make use of wearable products, such as Apple Watch, Oura Rings, Fitbits, and WHOOP, to “take control of their health.” Less than …

    • Time is Money and Money is Time…What is an SBD Worth?June 6th, 2025

      We have written many posts (here, here, here, and more) about the impact of the reductions in force (RIFs) on various activities across FDA. One area where the RIFs are beginning to have an impact is with respect to Small Business Determination (SBD) requests submitted …

    • “Radical Transparency” and “Deregulation” from Trump and RFK Jr.’s FDA . . . Unless it’s Useful to the Device IndustryMay 23rd, 2025

      Last week, FDA published a Request for Information (RFI) (here) seeking input from the public on its efforts to “to identify and eliminate outdated or unnecessary regulations.”  The Announcement raises several questions and issues for the device industry. 10-for-1 Rule and its effect on de novos.  …

    • Evidence v. Belief: What a Kennedy Appointment Could Mean to FDA and Public HealthNovember 19th, 2024

      On Thursday, November 14, President-Elect Trump announced his pick of Robert Kennedy, Jr., for Secretary of Health and Human Services (HHS). Although not altogether surprising, the formality of an official announcement still came as a shock to many of us who work in areas regulated …